Page last updated: 2024-11-02

4-phenylbutyric acid and Pigmentary Retinopathy

4-phenylbutyric acid has been researched along with Pigmentary Retinopathy in 2 studies

4-phenylbutyric acid: RN refers to the parent cpd
4-phenylbutyric acid : A monocarboxylic acid the structure of which is that of butyric acid substituted with a phenyl group at C-4. It is a histone deacetylase inhibitor that displays anticancer activity. It inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. It also inhibits protein isoprenylation, depletes plasma glutamine, increases production of foetal haemoglobin through transcriptional activation of the gamma-globin gene and affects hPPARgamma activation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qiu, Y1
Yao, J1
Jia, L1
Thompson, DA1
Zacks, DN1
Bonapace, G1
Waheed, A1
Shah, GN1
Sly, WS1

Other Studies

2 other studies available for 4-phenylbutyric acid and Pigmentary Retinopathy

ArticleYear
Shifting the balance of autophagy and proteasome activation reduces proteotoxic cell death: a novel therapeutic approach for restoring photoreceptor homeostasis.
    Cell death & disease, 2019, 07-18, Volume: 10, Issue:8

    Topics: Animals; Autophagy; Cell Death; Disease Models, Animal; Endoplasmic Reticulum; Endoplasmic Reticulum

2019
Chemical chaperones protect from effects of apoptosis-inducing mutation in carbonic anhydrase IV identified in retinitis pigmentosa 17.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Aug-17, Volume: 101, Issue:33

    Topics: Acetazolamide; Animals; Apoptosis; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IV; COS Cells;

2004